Is Miralax (Polyethylene Glycol) safe in pregnancy?
Common uses
Constipation
How Miralax (Polyethylene Glycol) works and why pregnancy changes the math
Miralax (Polyethylene Glycol) contains polyethylene glycol 3350. It pulls water into your intestines and softens stool, but it is not absorbed systemically — it works locally and passes through with the stool. There is essentially no placental transfer to worry about because the active ingredient does not enter your bloodstream in meaningful amounts.
That mechanism is exactly why obstetricians reach for this as a first-line constipation option in pregnancy. Pregnancy constipation is extremely common, driven by progesterone slowing the gut and iron supplements making everything firmer. Daily use of this is well-tolerated and not associated with the dependency concerns that stimulant laxatives can cause. Pair it with plenty of water, fiber, and movement, and most pregnancy constipation resolves.
How Miralax (Polyethylene Glycol) risk changes by trimester
The clinical reasoning behind the verdict
PEG 3350 is not absorbed systemically; works locally in the gut. Considered safe.
Dosing and what to do if symptoms keep going
Pregnancy dosing for Miralax (Polyethylene Glycol) generally follows standard adult guidance unless your provider has directed otherwise. Pregnancy changes how your body absorbs, distributes, and clears many medications, so doses that worked before may need adjustment as pregnancy progresses.
If symptoms are not responding to standard dosing of Miralax (Polyethylene Glycol), that is a conversation with your prescriber rather than a reason to escalate on your own. Pregnancy is a time when changes to medication should happen with provider involvement, both because the underlying condition may be evolving and because pregnancy-safe alternatives may be available.
Safer alternatives and how to choose between them
First-line for pregnancy constipation if dietary changes aren't enough.
The right alternative depends on what Miralax (Polyethylene Glycol) was being used to treat. For mild symptoms, non-medication approaches often work — saline rinses for congestion, ice for swelling, heat for muscle pain, rest for fatigue. For ongoing conditions, pregnancy-safe medications usually exist and are best identified with your provider's input.
The trap to avoid is stopping a needed medication abruptly without a replacement plan, especially for chronic conditions like hypertension, diabetes, depression, or autoimmune disease. Untreated maternal conditions usually carry pregnancy risks of their own, sometimes larger than the risks of the medication being avoided. A pregnancy-aware substitute usually beats stopping treatment.
How to bring this up with your OB, midwife, or pharmacist
The most useful conversation with a provider about Miralax (Polyethylene Glycol) starts with what you actually want to know rather than a yes-or-no question. Try one of these:
- "I take Miralax (Polyethylene Glycol) sometimes for [symptom]. Is the dose I am using fine, or would you adjust it for pregnancy?" This invites a specific answer rather than a generic "talk to your provider."
- "What is your default for [the symptom]? If your default does not work for me, what is the next step?" Knowing the escalation plan ahead of time saves time when you actually need it.
- "I have been on Miralax (Polyethylene Glycol) for [condition] since before I got pregnant. What is your read on continuing versus switching?" For chronic medications, this is the most important question, and the answer is rarely "just stop."
Pharmacists are an underused resource here. The pharmacist at your usual pharmacy can pull up your records, check interactions, and answer pregnancy-medication questions without a co-pay or an appointment. For over-the-counter products especially, a pharmacist conversation is often faster than waiting for an obstetric callback.
What recent research has been saying about Miralax (Polyethylene Glycol)
The literature on Miralax (Polyethylene Glycol) in pregnancy continues to evolve as more population-level data accumulates and as researchers control more carefully for confounding factors. The pregnancy-specific evidence base for any given medication is rarely as deep as the general adult evidence base, so cautious clinical interpretation and individualized provider conversation remain the right approach as guidance updates.
Sources and further reading
ACOG Constipation 2024
Check another medication
Other pregnancy safety lookups
Or visit the Pregnancy Safety Guide to search across all 460+ lookups.